2018
DOI: 10.1016/j.colsurfb.2017.12.050
|View full text |Cite
|
Sign up to set email alerts
|

Attachment of nanoparticulate drug-release systems on poly(ε-caprolactone) nanofibers via a graftpolymer as interlayer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
59
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 35 publications
(68 citation statements)
references
References 63 publications
7
59
0
Order By: Relevance
“…In further approaches, we want to optimize the PCL fiber patches by increasing the pores to sizes greater than 300 μm for optimal vascularization (Kuboki, Jin, & Takita, ). Moreover, the cationic amino groups provided by chitosan open a great variety to adsorb oppositely charged nanoparticulate drug‐carrier systems (Sydow et al, ) or to enable further chemical modifications of the implant surface (de Cassan et al, ; Hofer & Tuan, ; Lopiz et al, ). Especially, growth or differentiation factors that support tendon repair processes both on the tendon‐muscular as well as on the tendon‐bone side are of great interest in this context.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…In further approaches, we want to optimize the PCL fiber patches by increasing the pores to sizes greater than 300 μm for optimal vascularization (Kuboki, Jin, & Takita, ). Moreover, the cationic amino groups provided by chitosan open a great variety to adsorb oppositely charged nanoparticulate drug‐carrier systems (Sydow et al, ) or to enable further chemical modifications of the implant surface (de Cassan et al, ; Hofer & Tuan, ; Lopiz et al, ). Especially, growth or differentiation factors that support tendon repair processes both on the tendon‐muscular as well as on the tendon‐bone side are of great interest in this context.…”
Section: Discussionmentioning
confidence: 99%
“…These scaffolds were then modified using CS‐g‐PCL (described in de Cassan et al, ). CS‐g‐PCL is bound to PCL fiber surface by crystallization according to established methods (Wang et al, ).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Therefore, PCL is unattractive for biomedical applications (Nair & Laurencin, ). Furthermore, because PCL is an aliphatic polyester, it lacks access to easy modifications, and chemically more reactive moieties have to be introduced by various approaches such as plasma or wet chemical treatment, blending, and attachment of graft copolymers (Fu, Sammons, Bertóti, Jenkins, & Dong, ; Tallawi et al, ; de Cassan et al, ). These modifications can help overcome these weaknesses of PCL, while maintaining good properties, and create implants applicable in a variety of orthopaedic areas, for example, the use in therapy of chronic rotator cuff tears.…”
Section: Introductionmentioning
confidence: 99%